Literature DB >> 25043793

A new and standardized method to sample and analyse vitreous samples by the Cellient automated cell block system.

Rita Van Ginderdeuren1, Joachim Van Calster, Peter Stalmans, Joost Van den Oord.   

Abstract

PURPOSE: In this prospective study, a universal protocol for sampling and analysing vitreous material was investigated. Vitreous biopsies are difficult to handle because of the paucity of cells and the gelatinous structure of the vitreous. Histopathological analysis of the vitreous is useful in difficult uveitis cases to differentiate uveitis from lymphoma or infection and to define the type of cellular reaction.
METHODS: Hundred consecutive vitreous samples were analysed with the Cellient tissue processor (Hologic). This machine is a fully automated processor starting from a specified container with PreservCyt (fixative fluid) with cells to paraffin. Cytology was compared with fixatives Cytolyt (contains a mucolyticum) and PreservCyt. Routine histochemical and immunostainings were evaluated.
RESULTS: In 92% of the cases, sufficient material was found for diagnosis. In 14%, a Cytolyt wash was necessary to prevent clotting of the tubes in the Cellient due to the viscosity of the sample. In 23%, the diagnosis was an acute inflammation (presence of granulocytes); in 33%, chronic active inflammation (presence of T lymphocytes); in 33%, low-grade inflammation (presence of CD68 cells, without T lymphocytes); and in 3%, a malignant process.
CONCLUSION: A standardized protocol for sampling and handling vitreous biopsies, fixing in PreservCyt and processing by the Cellient gives a satisfactory result in morphology, number of cells and possibility of immuno-histochemical stainings. The diagnosis can be established or confirmed in more than 90% of cases.
© 2014 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cellient®; automated system; cell block; vitreous biopsies

Mesh:

Substances:

Year:  2014        PMID: 25043793     DOI: 10.1111/aos.12360

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  2 in total

1.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

2.  Diagnostic efficacy of cell block method for vitreoretinal lymphoma.

Authors:  Satoru Kase; Kenichi Namba; Daiju Iwata; Kazuomi Mizuuchi; Nobuyoshi Kitaichi; Yoshiaki Tagawa; Hiromi Okada-Kanno; Yoshihiro Matsuno; Susumu Ishida
Journal:  Diagn Pathol       Date:  2016-03-17       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.